Increased leptin and tumour necrosis factor alpha per unit fat mass in hypopituitary women without growth hormone treatment.

BACKGROUND The adipocyte products, leptin and tumour necrosis factor (TNF)alpha, are associated with atherosclerotic diseases and may be factors contributing to the enhanced cardiovascular risk in hypopituitary patients with growth hormone (GH) deficiency. OBJECTIVE To investigate whether leptin and TNFalpha are increased in a group of hypopituitary women previously found to have increased cardiovascular morbidity, and to compare them with matched individuals of the same sex and age and with similar body composition. DESIGN AND PATIENTS Thirty-three GH-deficient women with a median age of 64 years (range 39-77 years) were investigated cross-sectionally. The patients were compared with 33 controls matched for sex, age, smoking habits, educational level and residence. METHODS Body composition was measured by bioimpedance analysis. Fasting concentrations of leptin, TNFalpha and insulin were analysed in patients and controls. RESULTS There was no significant difference in body mass index or fat mass between patients and controls (both P > or =0.4). Serum leptin did not differ significantly between patients and controls. However, when serum leptin concentrations were expressed per kilogram fat mass, the patients had significantly greater concentrations (P=0.01). Serum TNFalpha and TNFalpha per kilogram fat mass were also significantly greater in the patients (both P=0.001). In contrast, serum insulin did not differ significantly between patients and controls. In the patients, serum leptin concentrations correlated positively with kilogram fat mass (r=0.54, P=0.002). Leptin concentration per kilogram fat mass was positively correlated with insulin (r=0.40, P=0.03). CONCLUSIONS In contrast to serum concentrations of TNFalpha, serum leptin did not differ from that in controls, implying that leptin is not a major contributor to the previously found increase in cardiovascular morbidity in the hypopituitary women investigated. However, the patients had increased leptin concentrations per unit fat mass, indicating an altered adipocyte secretory function in this group.

[1]  G. Hotamisligil,et al.  Mechanisms of TNF-alpha-induced insulin resistance. , 2009 .

[2]  J. Henriksen,et al.  Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin. , 2000, Clinical science.

[3]  C. Bouchard,et al.  Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: evidence from both a cross-sectional and an intervention study. , 2000, The Journal of clinical endocrinology and metabolism.

[4]  U. Keller,et al.  Bioelectrical impedance analysis during acute changes of extracellular osmolality in man. , 2000, Clinical nutrition.

[5]  L. Hagmar,et al.  Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. , 2000, The Journal of clinical endocrinology and metabolism.

[6]  T. Olsson,et al.  Leptin is associated with increased risk of myocardial infarction , 1999, Journal of internal medicine.

[7]  S. Norgren,et al.  Growth Hormone Treatment Downregulates Serum Leptin Levels in Children Independent of Changes in Body Mass Index , 1999, Hormone Research in Paediatrics.

[8]  A. Ruello,et al.  Relationship between plasma leptin levels and the tumor necrosis factor-α system in obese subjects , 1999, International Journal of Obesity.

[9]  T. Tanaka,,et al.  Effect of growth hormone (GH) on serum concentrations of leptin: study in patients with acromegaly and GH deficiency. , 1998, The Journal of clinical endocrinology and metabolism.

[10]  P. Eriksson,et al.  Leptin secretion from subcutaneous and visceral adipose tissue in women. , 1998, Diabetes.

[11]  C. Gravholt,et al.  Increased levels but preserved diurnal variation of serum leptin in GH-deficient patients: lack of impact of different modes of GH administration. , 1998, European journal of endocrinology.

[12]  M. Zecca,et al.  Modulating effect of human growth hormone on tumour necrosis factor-alpha and interleukin-1beta. , 1998, European journal of endocrinology.

[13]  B. Ahrén,et al.  Leptin--a regulator of islet function?: its plasma levels correlate with glucagon and insulin secretion in healthy women. , 1997, Metabolism: clinical and experimental.

[14]  D. Strachan,et al.  Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. , 1997, Heart.

[15]  Judith E. Adams,et al.  Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects , 1997, Clinical endocrinology.

[16]  N. Sato,et al.  Estrogen increases in vivo leptin production in rats and human subjects. , 1997, The Journal of endocrinology.

[17]  D. Johnston,et al.  Elevated leptin concentrations in growth hormone‐deficient hypopituitary adults , 1997, Clinical endocrinology.

[18]  H. Arnqvist,et al.  Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment , 1997, Clinical endocrinology.

[19]  H. Orskov,et al.  Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year. , 1997, Metabolism: clinical and experimental.

[20]  W. Garvey,et al.  The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. , 1997, The Journal of clinical endocrinology and metabolism.

[21]  E. Froesch,et al.  Effects of growth hormone (GH) and insulin-like growth factor-I on serum leptin in GH-deficient adults. , 1997, Diabetologia.

[22]  M. Saad,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Sexual Dimorphism in Plasma Leptin Concentration* , 2022 .

[23]  L. Hagmar,et al.  Increased cerebrovascular mortality in patients with hypopituitarism , 1997, Clinical endocrinology.

[24]  S. Phinney,et al.  Gender differences in plasma leptin concentrations , 1996, Nature Medicine.

[25]  E. Froesch,et al.  Reduced ob mRNA in hypophysectomised rats is not restored by growth hormone (GH), but further suppressed by exogenously administered insulin-like growth factor (IGF) I. , 1996, Biochemical and biophysical research communications.

[26]  S. Klein,et al.  Radioimmunoassay of leptin in human plasma. , 1996, Clinical chemistry.

[27]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[28]  F. Lönnqvist,et al.  Overexpression of the obese (ob) gene in adipose tissue of human obese subjects , 1995, Nature Medicine.

[29]  H. Koppeschaar,et al.  Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects. , 1995, The American journal of clinical nutrition.

[30]  R. Clayton,et al.  Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin‐like growth factor‐l and urinary growth hormone excretion , 1995, Clinical endocrinology.

[31]  S. Shalet,et al.  The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism , 1994, Clinical endocrinology.

[32]  H. de Boer,et al.  Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis. , 1992, The Journal of clinical endocrinology and metabolism.

[33]  K. Hall,et al.  Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. , 1991, Acta endocrinologica.

[34]  B. Bengtsson,et al.  Premature mortality due to cardiovascular disease in hypopituitarism , 1990, The Lancet.

[35]  M. Littley,et al.  Hypopituitarism following external radiotherapy for pituitary tumours in adults. , 1989, The Quarterly journal of medicine.

[36]  M. Raben,et al.  Effect of growth hormone on plasma fatty acids. , 1959, The Journal of clinical investigation.

[37]  O. Serri,et al.  Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy. , 1999, The Journal of clinical endocrinology and metabolism.

[38]  B. Lamarche.  Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease , 1998, Coronary artery disease.

[39]  J. Hall,et al.  Chronic leptin infusion increases arterial pressure. , 1998, Hypertension.

[40]  J. Cunningham,et al.  The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. , 1995, The Journal of clinical endocrinology and metabolism.